134 related articles for article (PubMed ID: 34153575)
1. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo.
Leblanc R; Kashyap R; Barral K; Egea-Jimenez AL; Kovalskyy D; Feracci M; Garcia M; Derviaux C; Betzi S; Ghossoub R; Platonov M; Roche P; Morelli X; Hoffer L; Zimmermann P
J Extracell Vesicles; 2020 Dec; 10(2):e12039. PubMed ID: 33343836
[TBL] [Abstract][Full Text] [Related]
3. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
Grootjans JJ; Reekmans G; Ceulemans H; David G
J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
[TBL] [Abstract][Full Text] [Related]
4. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
[TBL] [Abstract][Full Text] [Related]
5. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.
Roucourt B; Meeussen S; Bao J; Zimmermann P; David G
Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" Approach.
Hoffer L; Garcia M; Leblanc R; Feracci M; Betzi S; Ben Yaala K; Daulat AM; Zimmermann P; Roche P; Barral K; Morelli X
J Med Chem; 2023 Apr; 66(7):4633-4658. PubMed ID: 36939673
[TBL] [Abstract][Full Text] [Related]
7. Syntenin mediates SRC function in exosomal cell-to-cell communication.
Imjeti NS; Menck K; Egea-Jimenez AL; Lecointre C; Lembo F; Bouguenina H; Badache A; Ghossoub R; David G; Roche S; Zimmermann P
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12495-12500. PubMed ID: 29109268
[TBL] [Abstract][Full Text] [Related]
8. Heparanase Involvement in Exosome Formation.
David G; Zimmermann P
Adv Exp Med Biol; 2020; 1221():285-307. PubMed ID: 32274714
[TBL] [Abstract][Full Text] [Related]
9. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
Shimada T; Yasuda S; Sugiura H; Yamagata K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
[TBL] [Abstract][Full Text] [Related]
10. Syntenin and syndecan in the biogenesis of exosomes.
Friand V; David G; Zimmermann P
Biol Cell; 2015 Oct; 107(10):331-41. PubMed ID: 26032692
[TBL] [Abstract][Full Text] [Related]
11. Syntenin-knock out reduces exosome turnover and viral transduction.
Kashyap R; Balzano M; Lechat B; Lambaerts K; Egea-Jimenez AL; Lembo F; Fares J; Meeussen S; Kügler S; Roebroek A; David G; Zimmermann P
Sci Rep; 2021 Feb; 11(1):4083. PubMed ID: 33602969
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
Baietti MF; Zhang Z; Mortier E; Melchior A; Degeest G; Geeraerts A; Ivarsson Y; Depoortere F; Coomans C; Vermeiren E; Zimmermann P; David G
Nat Cell Biol; 2012 Jun; 14(7):677-85. PubMed ID: 22660413
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin-6 negatively regulates exosome production.
Ghossoub R; Chéry M; Audebert S; Leblanc R; Egea-Jimenez AL; Lembo F; Mammar S; Le Dez F; Camoin L; Borg JP; Rubinstein E; David G; Zimmermann P
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5913-5922. PubMed ID: 32108028
[TBL] [Abstract][Full Text] [Related]
14. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
15. Syntenin: Key player in cancer exosome biogenesis and uptake?
Fares J; Kashyap R; Zimmermann P
Cell Adh Migr; 2017 Mar; 11(2):124-126. PubMed ID: 27589080
[TBL] [Abstract][Full Text] [Related]
16. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
17. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.
Luyten A; Mortier E; Van Campenhout C; Taelman V; Degeest G; Wuytens G; Lambaerts K; David G; Bellefroid EJ; Zimmermann P
Mol Biol Cell; 2008 Apr; 19(4):1594-604. PubMed ID: 18256285
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
19. PDZ tandem of human syntenin: crystal structure and functional properties.
Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
[TBL] [Abstract][Full Text] [Related]
20. Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
Egea-Jimenez AL; Gallardo R; Garcia-Pino A; Ivarsson Y; Wawrzyniak AM; Kashyap R; Loris R; Schymkowitz J; Rousseau F; Zimmermann P
Nat Commun; 2016 Jul; 7():12101. PubMed ID: 27386966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
